
Long V. Le
Supervisory Patent Examiner (ID: 2116, Phone: (571)272-0823 , Office: P/3768 )
| Most Active Art Unit | 1743 |
| Art Unit(s) | 1801, 1754, 1641, 3737, 1313, 3768, 1809, 1743 |
| Total Applications | 805 |
| Issued Applications | 510 |
| Pending Applications | 122 |
| Abandoned Applications | 173 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18364665
[patent_doc_number] => 20230146256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/918835
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918835 | SARS-CoV-2 spike receptor binding domain and compositions and methods thereof | Mar 24, 2021 | Issued |
Array
(
[id] => 18391641
[patent_doc_number] => 20230159859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => HIGHLY ALKALINE TEXTILE DETERGENT COMPRISING PROTEASE
[patent_app_type] => utility
[patent_app_number] => 17/920410
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920410 | Highly alkaline textile detergent comprising protease | Mar 22, 2021 | Issued |
Array
(
[id] => 18420442
[patent_doc_number] => 20230174904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => HIGHLY ALKALINE TEXTILE WASHING AGENT COMPRISING PROTEASE
[patent_app_type] => utility
[patent_app_number] => 17/920407
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920407 | Highly alkaline textile washing agent comprising protease | Mar 22, 2021 | Issued |
Array
(
[id] => 16932812
[patent_doc_number] => 20210198701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => FERMENTATIVE PRODUCTION OF ETHANOL FROM GLUCOSE, GALACTOSE AND ARABINOSE EMPLOYING A RECOMBINANT YEAST STRAIN
[patent_app_type] => utility
[patent_app_number] => 17/199823
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199823 | Fermentative production of ethanol from glucose, galactose and arabinose employing a recombinant yeast strain | Mar 11, 2021 | Issued |
Array
(
[id] => 18421571
[patent_doc_number] => 20230176034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Engineered PlyAB Nanopores and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/905911
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905911 | Engineered PlyAB Nanopores and Uses Thereof | Mar 10, 2021 | Pending |
Array
(
[id] => 16961575
[patent_doc_number] => 20210213074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/196271
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196271 | Compositions and methods for improving mitochondrial function | Mar 8, 2021 | Issued |
Array
(
[id] => 18333666
[patent_doc_number] => 20230125614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/905583
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | Mar 4, 2021 | Pending |
Array
(
[id] => 20356252
[patent_doc_number] => 12472231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compositions of anti-viral peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/930626
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 26
[patent_no_of_words] => 10664
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930626 | Compositions of anti-viral peptides and methods of use thereof | Mar 1, 2021 | Issued |
Array
(
[id] => 18350317
[patent_doc_number] => 20230138428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => CHIMERIC RECEPTORS FOR USE IN ENGINEERED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/802018
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802018 | CHIMERIC RECEPTORS FOR USE IN ENGINEERED CELLS | Feb 23, 2021 | Abandoned |
Array
(
[id] => 20142850
[patent_doc_number] => 12377165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Exosome comprising photocleavable protein, and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/798524
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 2022
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798524 | Exosome comprising photocleavable protein, and use thereof | Feb 7, 2021 | Issued |
Array
(
[id] => 20578474
[patent_doc_number] => 12570716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Anti-dinitrophenol chimeric antigen receptors
[patent_app_type] => utility
[patent_app_number] => 17/758959
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7747
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758959 | Anti-dinitrophenol chimeric antigen receptors | Feb 1, 2021 | Issued |
Array
(
[id] => 16878243
[patent_doc_number] => 11028379
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-08
[patent_title] => FCE mRNA capping enzyme compositions, methods and kits
[patent_app_type] => utility
[patent_app_number] => 17/160256
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11336
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160256 | FCE mRNA capping enzyme compositions, methods and kits | Jan 26, 2021 | Issued |
Array
(
[id] => 20438840
[patent_doc_number] => 12509668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Engineered polymerases and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 18/021270
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18260
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021270 | Engineered polymerases and methods of using the same | Jan 25, 2021 | Issued |
Array
(
[id] => 18318955
[patent_doc_number] => 20230117083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHODS OF NUCLEIC ACID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/794320
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794320 | METHODS OF NUCLEIC ACID SYNTHESIS | Jan 21, 2021 | Pending |
Array
(
[id] => 16962783
[patent_doc_number] => 20210214282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS AND COMPOSITIONS FOR IMPROVING PLANT TRAITS
[patent_app_type] => utility
[patent_app_number] => 17/148173
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148173 | Methods and compositions for improving plant traits | Jan 12, 2021 | Issued |
Array
(
[id] => 18196218
[patent_doc_number] => 20230049737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/786168
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | Dec 29, 2020 | Pending |
Array
(
[id] => 17938626
[patent_doc_number] => 11473070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Increased polypeptide production yields of butyrylcholinesterase polypeptides for therapeutic use
[patent_app_type] => utility
[patent_app_number] => 17/129736
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8205
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129736 | Increased polypeptide production yields of butyrylcholinesterase polypeptides for therapeutic use | Dec 20, 2020 | Issued |
Array
(
[id] => 18166208
[patent_doc_number] => 20230032810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => METHODS AND COMPOSITIONS FOR HIGH EFFICIENCY HOMOLOGOUS REPAIR-BASED GENE EDITING
[patent_app_type] => utility
[patent_app_number] => 17/786478
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786478 | METHODS AND COMPOSITIONS FOR HIGH EFFICIENCY HOMOLOGOUS REPAIR-BASED GENE EDITING | Dec 16, 2020 | Abandoned |
Array
(
[id] => 16999502
[patent_doc_number] => 11078294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Prevention of disulfide bond reduction during recombinant production of polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/124314
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 41
[patent_no_of_words] => 29427
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124314 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Dec 15, 2020 | Issued |
Array
(
[id] => 19381257
[patent_doc_number] => 20240271127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHODS OF ENHANCING AND EXPEDITING EXPRESSION OF ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/784796
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784796 | METHODS OF ENHANCING AND EXPEDITING EXPRESSION OF ANTIBODIES | Dec 14, 2020 | Abandoned |